OpenVSafe by OpenVAERS
Search V-safe

BGC-28407-37429

3 vaccinations 11 coded responses 33 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
51-55
ZIP prefix
007 / PR
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino
Registered dependents
AP6-31912-44868 Child or adolescent in my care · Male · 2021-11-16

Timeline

  1. 2021-03-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-19
    Registered in v-safe
  3. 2021-03-19
    Survey response — day 7, dose 1
    MedDRA: Balance disorder, Induration, Mobility decreased — Feeling: Good · Site: Pain
    Free text: Sentí los primeros días que me debía mover lenta para no marearme o perder balance. Fue una sensación extraña q ne duro como 7 días.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-23
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-03-30
    Dose 2 — Pfizer-BioNTech
  6. 2021-03-30
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Abdominal pain, Blood pressure decreased, Dizziness, Gastrooesophageal reflux disease — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Free text: Mareos y una sensación de presión baja. No pude tomar la presión, pero me comí un dulce y mejoró. Tuve dolor abdominal, solo en la noche y sensación de reflujo.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  9. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-04-06
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-04-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-20
    Survey response — day 21, dose 2
    MedDRA: Unevaluable event — Feeling: Good
    Free text: En la primera dosis me dio un fuerte dolor de estómago en la noche que nunca había sentido. En la mañana al evacuar se me fue. Hace 3 días me volvió a dar. Me parece raro. Por eso lo comento.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-06-29
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-09-28
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-10-05
    Dose 3 — Pfizer-BioNTech
  22. 2021-10-05
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  23. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    MedDRA releases: 2024-11
  24. 2021-10-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Site: Redness · Fever · Headache, Joint pains, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  25. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness — Feeling: Fair · Fever · Headache, Nausea
    MedDRA releases: 2024-11
  26. 2021-10-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hyperhidrosis — Feeling: Good · Headache
    MedDRA releases: 2024-11
  27. 2021-10-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-12
    Survey response — day 7, dose 3
    MedDRA: Dizziness — Feeling: Good
    MedDRA releases: 2024-11
  30. 2021-10-20
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-26
    Survey response — day 21, dose 3
    MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  32. 2021-11-02
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-11-09
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-16
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-01-04
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  36. 2022-04-05
    Survey response — 6 months, dose 3
    MedDRA: Blood glucose abnormal, Type 2 diabetes mellitus — Feeling: Fair
    MedDRA releases: 2024-11
  37. 2022-10-05
    Survey response — 12 months, dose 3
    MedDRA: Aphonia, Diarrhoea, Myalgia, Oropharyngeal pain, Pyrexia, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  38. 2022-10-05
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  39. 2022-10-06
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Pfizer-BioNTech
22021-03-30Pfizer-BioNTech
32021-10-05Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 5 — day 7, dose 1

2021-03-19

Systemic reaction (other): Sentí los primeros días que me debía mover lenta para no marearme o perder balance. Fue una sensación extraña q ne duro como 7 días.

Release 6 — days 1–6 daily, dose 2

2021-03-31

Systemic reaction (other): Mareos y una sensación de presión baja. No pude tomar la presión, pero me comí un dulce y mejoró. Tuve dolor abdominal, solo en la noche y sensación de reflujo.

Release 7 — day 21, dose 2

2021-04-20

Symptoms: En la primera dosis me dio un fuerte dolor de estómago en la noche que nunca había sentido. En la mañana al evacuar se me fue. Hace 3 días me volvió a dar. Me parece raro. Por eso lo comento.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAphonia · · ✓
SDBlood glucose abnormal · · ✓
SDDiarrhoea · · ✓
SDHeadache · · ✓
SDMyalgia · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDType 2 diabetes mellitus · · ✓
SDUnevaluable event ✓ ✓ ✓
SDVomiting · · ✓
SROAbdominal pain ✓ ✓ ✓
SROBalance disorder ✓ ✓ ✓
SROBlood pressure decreased ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROGastrooesophageal reflux disease ✓ ✓ ✓
SROHyperhidrosis · · ✓
SROInduration ✓ ✓ ✓
SROMobility decreased ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release